Development and psychometric evaluation of 2 age-stratified versions of the pediatric GERD symptom and quality of life questionnaire

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 5, 2011, Pages 514-522

  Kleinman, Leah ^a   Nelson, Suzanne ^b   Kothari Talwar, Smita ^c   Roberts, Laurie ^a   Orenstein, Susan R ^d   Mody, Reema R ^c   Hassall, Eric ^e   Gold, Ben ^f   Revicki, Dennis A ^a   Dabbous, Omar ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c TAKEDA PHARMACEUTICALS   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastroesophageal reflux disease; health related quality of life; instrument development; pediatric; reliability; validity

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; DISEASE SEVERITY; FACTORIAL ANALYSIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE SYMPTOM AND QUALITY OF LIFE QUESTIONNAIRE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REPRODUCIBILITY; SCHOOL CHILD; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GASTROESOPHAGEAL REFLUX; HUMANS; PARENTS; PEDIATRICS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCHOOLS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 79955567044     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318205970e     Document Type: Article

References (31)

1. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidencebased consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104:1278-95. Quiz 96.
2. Gupta SK, Hassall E, Chiu YL, et al. Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci 2006;51:858-63. (Pubitemid 44030803)
3. Michail S. Gastroesophageal reflux. Pediatr Rev 2007;28:101-10. (Pubitemid 46495838)
4. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498-547.
5. Diaz DM, Winter HS, Colletti RB, et al. Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007;45:56-64. (Pubitemid 47012331)
6. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-63.
7. Kleinman L, Revicki DA, Flood E. Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children. Curr Gastroenterol Rep 2006;8:230-6. (Pubitemid 43862772)
8. Revicki DA,Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104:252-8. (Pubitemid 28163170)
9. Malaty HM, O'Malley KJ, Abudayyeh S, et al. Multidimensional measure for gastroesophageal reflux disease (MM-GERD) symptoms in children: a population-based study. Acta Paediatr 2008;97:1292-7.
10. Deal L, Gold BD, Gremse DA, et al. Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation. J Pediatr Gastroenterol Nutr 2005;41:178-85. (Pubitemid 41099365)
11. Tolia V, Bishop PR, Tsou VM, et al. Multicenter, randomized, doubleblind study comparing 10, 20 and 40mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2006;42:384-91. (Pubitemid 43841020)
12. Food and Drug Administration. Guidance for Industry on Patient- Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Fed Regist 2009;74:65132-3.
13. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10(Suppl 2):S125-37. (Pubitemid 350098929)
14. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on healthrelated quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900. (Pubitemid 32210183)
15. Gorsuch RL. Factor Analysis. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1983.
16. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
17. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15. (Pubitemid 20025670)
18. Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ 1998;316:690-3. (Pubitemid 28121037)
19. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7. (Pubitemid 24034293)
20. Revicki DA, Sorensen S, Maton PN, et al. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998;16:284-91. (Pubitemid 128527394)
21. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001;39:800-12. (Pubitemid 33686263)
22. Youssef NN, Murphy TG, Langseder AL, et al. Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics 2006;117:54-9. (Pubitemid 46050519)
23. Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and user's guide for multi-trait analysis program on the microcomputer. Behav Res Meth Instr Comp 1990;22:167-75.
24. Reeve BR, Fayers P. Applying item response theory modeling for evaluating questionnaire item and scale properties. In: Fayers P, Hays R, eds. Assessing Quality of Life in Clinical Trials. 2nd ed. New York: Oxford University Press; 2005: 55-73.
25. Van der Linden WJ, Hambleton RK, eds. Handbook of Modern Item Response Theory. New York: Springer-Velag; 1997.
26. Hays RD, Revicki DA. Reliability and validity, including responsiveness. In: Fayers P, Hays RD, eds. Assessing Quality of Life in Clinical Trials. 2nd ed. New York: Oxford University Press; 2005.
27. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):S178-89.
28. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
29. Acierno S, Chilcote H, Edwards T, et al. Development of a quality of life instrument for pediatric gastroesophageal reflux disease: qualitative interviews. J Pediatr Gastroenterol Nutr 2010;50:486-92.
30. Stanford EA, Chambers CT, Craig KD. The role of developmental factors in predicting young children's use of a self-report scale for pain. Pain 2006;120:16-23. (Pubitemid 43077165)
31. von Baeyer CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain 2007;127:140-50. (Pubitemid 44959437)